Ribociclib Inhibits P-gp-Mediated Multidrug Resistance in Human Epidermoid Carcinoma Cells

Ribociclib Inhibits P-gp-Mediated Multidrug Resistance in Human Epidermoid Carcinoma Cells

The efficacy of cancer chemotherapy can be attenuated or abrogated by multidrug resistance (MDR) in cancer cells. In this study, we determined the effect of the CDK4/6 inhibitor, ribociclib (or LEE011), on P-glycoprotein (P-gp)-mediated MDR in the human epidermoid carcinoma MDR cell line, KB-C2, whi...

Full description

Bibliographic Details
Main Authors:	Lei Zhang, Biwei Ye, Yunfeng Lin, Yi-Dong Li, Jing-Quan Wang, Zhuo Chen, Feng-Feng Ping, Zhe-Sheng Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-04-01
Series:	Frontiers in Pharmacology
Subjects:	cancer ribociclib-LEE011 multidrug resistance (MDR) cyclin dependent kinases CDKs 4 and 6 P-glycoprotein (ABCB1 protein)
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.867128/full

Similar Items

Ribociclib (LEE011) suppresses cell proliferation and induces apoptosis of MDA-MB-231 by inhibiting CDK4/6-cyclin D-Rb-E2F pathway
by: Tianqi Li, et al.
Published: (2019-12-01)

Recent advances of cyclin-dependent kinases as potential therapeutic targets in HR+/HER2− metastatic breast cancer: a focus on ribociclib
by: Edessa D, et al.
Published: (2017-12-01)

Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors
by: Federica Baldassari, et al.
Published: (2018-05-01)

Ribociclib-Induced Vitiligo: A Case Report
by: Nicolás Silvestre Torner, et al.
Published: (2022-05-01)

The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer
by: Lei Zhang, et al.
Published: (2020-01-01)

Identification and Empiric Evaluation of New Inhibitors of the Multidrug Transporter P-Glycoprotein (ABCB1)
by: Yasmeen Cheema, et al.
Published: (2023-03-01)

Cambium Reactivation Is Closely Related to the Cell-Cycle Gene Configuration in <i>Larix kaempferi</i>
by: Dong-Xia Cheng, et al.
Published: (2024-03-01)

Case Report: Ribociclib-induced phototoxicity presented as dyschromia with subsequent bullae formation
by: Jyun-Yan Jhan, et al.
Published: (2023-08-01)

Isobavachalcone as an Active Membrane Perturbing Agent and Inhibitor of ABCB1 Multidrug Transporter
by: Anna Palko-Łabuz, et al.
Published: (2021-07-01)

Progress in the studies on the molecular mechanisms associated with multidrug resistance in cancers
by: Lei Zhang, et al.
Published: (2023-03-01)

Cyclins and CDKs in the regulation of meiosis-specific events
by: Inés Palacios-Blanco, et al.
Published: (2022-11-01)

Circular RNA Controls Tumor Occurrence and Development via Cell Cycle Regulation
by: Liu F, et al.
Published: (2022-09-01)

Ribociclib for the treatment of hormone-positive HER2-negative breast cancer
by: I. P. Ganshina, et al.
Published: (2019-06-01)

Ribociclib in the first-line therapy for metastatic hormone-dependent HER2-negative breast cancer in patients with intact ovarian function
by: S. F. Menshikova, et al.
Published: (2018-11-01)

Low heritability in pharmacokinetics of talinolol: a pharmacogenetic twin study on the heritability of the pharmacokinetics of talinolol, a putative probe drug of MDR1 and other membrane transporters
by: Johannes Matthaei, et al.
Published: (2016-11-01)

The Flavonoid Metabolite 2,4,6-Trihydroxybenzoic Acid Is a CDK Inhibitor and an Anti-Proliferative Agent: A Potential Role in Cancer Prevention
by: Ranjini Sankaranarayanan, et al.
Published: (2019-03-01)

Cyclin-dependent kinases and rare developmental disorders
by: Pierre Colas
Published: (2020-08-01)

CADM1 impairs the effect of miR-1246 on promoting cell cycle progression in chemo-resistant leukemia cells
by: Bei Xie, et al.
Published: (2023-10-01)

The Regulation of Cyclins and Cyclin-Dependent Kinases in the Development of Gastric Cancer
by: Aadil Javed, et al.
Published: (2023-02-01)

P-glycoprotein and cancer: what do we currently know?
by: Carlos Pilotto Heming, et al.
Published: (2022-10-01)

ABCB1 C1236T, G2677T/A and C3435T polymorphisms in systemic lupus erythematosus patients
by: T.P. Gonzalez, et al.
Published: (2008-09-01)

First Sequencing of Caprine Mdr1 (Abcb1) mRNA Due to Suspected Neurological Adverse Drug Reaction in a Thuringian Goat Following Extra-Label Use of Doramectin
by: Daniela Nürnberger, et al.
Published: (2021-06-01)

The Involvement of Ubiquitination Machinery in Cell Cycle Regulation and Cancer Progression
by: Tingting Zou, et al.
Published: (2021-05-01)

An integrated assessment of the ADME properties of the CDK4/6 Inhibitor ribociclib utilizing preclinical in vitro, in vivo, and human ADME data
by: Alexander D. James, et al.
Published: (2020-06-01)

Case studies on clinical experience of targeted therapy ribociclib in combination with letrozole in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
by: M A Frolova, et al.
Published: (2018-06-01)

Inhibitors of Cyclin-Dependent Kinases: Types and Their Mechanism of Action
by: Paweł Łukasik, et al.
Published: (2021-03-01)

TMPE Derived from Saffron Natural Monoterpene as Cytotoxic and Multidrug Resistance Reversing Agent in Colon Cancer Cells
by: Kamila Środa-Pomianek, et al.
Published: (2020-10-01)

A Rare Class of New Dimeric Naphtoquiones from Diospyros lotus have Multidrug Reversal and Antiproliferative Effects
by: Dr. Abdur eRauf, et al.
Published: (2015-12-01)

Ribociclib Hybrid Lipid–Polymer Nanoparticle Preparation and Characterization for Cancer Treatment
by: Ramadan Al-Shdefat, et al.
Published: (2023-06-01)

Ribociclib in 1st line HR+ breast cancer treatment
by: L G Zhukova, et al.
Published: (2018-06-01)

TNF-α Modulates P-Glycoprotein Expression and Contributes to Cellular Proliferation via Extracellular Vesicles
by: Tandressa S. Berguetti, et al.
Published: (2019-05-01)

CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cells
by: Lei Zhang, et al.
Published: (2022-04-01)

Achillea spp.
by: Edward F. Gilman, et al.
Published: (2004-10-01)

Sugarcane Borer in Florida
by: D. G. Hall, et al.
Published: (2007-03-01)

How to Effectively Reduce Sales Call Reluctance
by: Kathryn Thornhill, et al.
Published: (2003-05-01)

Insect and Mite Management Suggestions for Commercial, Field-grown Statice Production
by: James F. Price, et al.
Published: (2009-04-01)

Zoysiagrass for Florida Lawns
by: J. Bryan Unruh, et al.
Published: (2011-06-01)

Reversal of Multidrug Resistance by Symmetrical Selenoesters in Colon Adenocarcinoma Cells
by: Bálint Rácz, et al.
Published: (2023-02-01)

Proton pump inhibitors may reduce the efficacy of ribociclib and palbociclib in metastatic breast cancer patients based on an observational study
by: Kadir Eser, et al.
Published: (2022-05-01)

Insight into Bortezomib Focusing on Its Efficacy against P-gp-Positive MDR Leukemia Cells
by: Tomáš Kyca, et al.
Published: (2021-05-01)